Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EMERGEX VACCINES LTD logo — A UK biotechnology company developing T cell-priming immune...

EMERGEX VACCINES LTD

A UK biotechnology company developing T cell-priming immune set-point candidates against infectious diseases.

Founded 2016 United Kingdom United Kingdom 1 employees Grant Total: $12.47M Biopharma, Biotechnology +1

General Information

Company Name EMERGEX VACCINES LTD
Founded Year 2016
Location United Kingdom United Kingdom +1
Employees 1
Industries Biopharma, Biotechnology, Health Care
Funding Stage Grant
Social

Get notified when EMERGEX VACCINES LTD moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EMERGEX VACCINES LTD

Emergex Vaccines is a pioneering UK biotechnology company that focuses on developing T cell-priming immune set-point candidates to combat infectious diseases. Founded in 2016, the company has its headquarters in the United Kingdom and an operating subsidiary in Pennsylvania, USA. Emergex's innovative approach involves utilizing synthetic T cell-priming immune set-point vaccine candidates to harness the body's natural CD8+ T cell immune response. The company's proprietary pipeline is designed to address a range of urgent health threats, including infectious diseases caused by viruses such as Betacoronavirus, Dengue Fever, and Universal Influenza A, as well as intra-cellular bacteria. Emergex has already completed two Phase I clinical trials for products targeting Dengue and Betacoronavirus disease, with other programs in development for Universal Influenza, Zika, Chikungunya, Smallpox/Monkeypox, Hand/Foot/Mouth Disease, a booster for Yellow Fever, and Francisella tularensis. The company's technology combines an empirically determined library of pathogen-derived protein fragments expressed on the surface of pathogen-infected cells with a self-assembling, ultrasmall carbohydrate-passivated nanocluster carrier system. This approach aims to deliver synthetic peptides to the skin-resident immune system to elicit a robust T cell response. In terms of funding, Emergex received a £490.53K grant investment from the Department of Health and Social Care (DHSC) on February 22, 2022. With its focus on leveraging T cell immunity to combat infectious diseases, Emergex Vaccines stands at the forefront of biopharma and biotechnology industries, offering promising solutions for global health challenges.

Taxonomy: T Cell-Priming Vaccines, Infectious Diseases, Clinical-Stage Biotechnology, Immunotherapy, Vaccine Development, Pandemic Prevention, Pathogen-Targeted Immunotherapy, Nanotechnology in Vaccines, Global Health, Immunoproteomics, Clinical Trials, Public Health, Disease Prevention, Low-Resource Environments

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 22 Feb 2022
Series A •••••• 1
Investor
09 Jan 2020
Grant •••••• 1
Investor
14 May 2018
Seed Round •••••• 1 •••• •••• 27 Jul 2017

FAQ About EMERGEX VACCINES LTD

A UK biotechnology company developing T cell-priming immune set-point candidates against infectious diseases.
EMERGEX VACCINES LTD was founded in 2016.
EMERGEX VACCINES LTD is headquartered in United Kingdom.
EMERGEX VACCINES LTD operates in the following industries: Biopharma, Biotechnology, Health Care.
EMERGEX VACCINES LTD has approximately 1 employees.
EMERGEX VACCINES LTD has completed 4 funding rounds, raising a total of $12.47M. The latest funding stage is Grant.

We're actively collecting intelligence on EMERGEX VACCINES LTD.

Track EMERGEX VACCINES LTD to get notified

Don't just browse. Track.

Signal Tracker monitors EMERGEX VACCINES LTD and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy